It is relevant that the two people most involved in the Nadilol re-purposing for pulmonary indications are Richard Bond and Mitchell glass. They were the two people involved twenty years ago in titrating beta-blockers for heart failure. Richard Bond is a Professor at Huston University and is still involved in academic research on the effect of Nadilol on the pathways to the lung. He has recently published a paper covering his research on this which shows that Nadilol is the only beta-blocker which will provide the necessary control to heal the lung. Mitchell Glass, of course, is the Chief Medical Officer at Invion.
IVX Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)